Gold Nanoparticles and Hepatitis B Virus Publisher Pubmed



Negahdari B^{1, 2} ; Darvishi M³ ; Saeedi AA³ Show Affiliations
Source: Artificial Cells# Nanomedicine and Biotechnology Published:2019

Abstract

Hepatitis B virus (HBV) infection is one of the major health issues in the world presently with high tendency of leading to hepatocarcinoma, cirrhosis, and liver cancer, especially if not properly managed. It has been estimated that there are about 2 billion people with a serological profile of HBV infection, and 360 million patients worldwide living with chronic HBV-associated liver disease, hence the need to find an efficient and precise diagnosis technique to drive a robust treatment for Hepatitis B virus cannot be over emphasized. The emergence of analytical device like biosensor which combines biological and physicochemical element to detect HBV in screened samples has been very helpful in providing a timely intervention to tame this virus. This review focuses on the current state of biosensor researches with respect to various in-depth application of gold nanoparticle for the detection of hepatitis B virus (HBV). © 2019, © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.